Annual Interest Expense
$1.17 B
-$66.00 M-5.36%
31 December 2023
Summary:
Bristol-Myers Squibb annual interest expense is currently $1.17 billion, with the most recent change of -$66.00 million (-5.36%) on 31 December 2023. During the last 3 years, it has fallen by -$254.00 million (-17.89%). BMY annual interest expense is now -17.89% below its all-time high of $1.42 billion, reached on 31 December 2020.BMY Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$505.00 M
-$16.00 M-3.07%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly interest expense is currently $505.00 million, with the most recent change of -$16.00 million (-3.07%) on 30 September 2024. Over the past year, it has increased by +$225.00 million (+80.36%). BMY quarterly interest expense is now -3.07% below its all-time high of $521.00 million, reached on 30 June 2024.BMY Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$1.77 B
+$225.00 M+14.59%
30 September 2024
Summary:
Bristol-Myers Squibb TTM interest expense is currently $1.77 billion, with the most recent change of +$225.00 million (+14.59%) on 30 September 2024. Over the past year, it has increased by +$623.00 million (+54.46%). BMY TTM interest expense is now at all-time high.BMY TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.4% | +80.4% | +54.5% |
| 3 y3 years | -17.9% | +54.0% | +29.4% |
| 5 y5 years | +537.2% | +141.6% | +315.8% |
BMY Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -17.9% | at low | -3.1% | +80.4% | at high | +54.5% |
| 5 y | 5 years | -17.9% | +537.2% | -3.1% | +141.6% | at high | +315.8% |
| alltime | all time | -17.9% | +704.1% | -3.1% | +1529.0% | at high | +3298.1% |
Bristol-Myers Squibb Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $505.00 M(-3.1%) | $1.77 B(+14.6%) |
| June 2024 | - | $521.00 M(+22.6%) | $1.54 B(+18.3%) |
| Mar 2024 | - | $425.00 M(+34.5%) | $1.30 B(+11.7%) |
| Dec 2023 | $1.17 B(-5.4%) | $316.00 M(+12.9%) | $1.17 B(+1.9%) |
| Sept 2023 | - | $280.00 M(-0.7%) | $1.14 B(-1.6%) |
| June 2023 | - | $282.00 M(-2.1%) | $1.16 B(-2.6%) |
| Mar 2023 | - | $288.00 M(-2.0%) | $1.19 B(-3.1%) |
| Dec 2022 | $1.23 B(-7.6%) | $294.00 M(-1.7%) | $1.23 B(-2.3%) |
| Sept 2022 | - | $299.00 M(-4.5%) | $1.26 B(-2.2%) |
| June 2022 | - | $313.00 M(-4.0%) | $1.29 B(-1.3%) |
| Mar 2022 | - | $326.00 M(+0.9%) | $1.31 B(-2.0%) |
| Dec 2021 | $1.33 B(-6.1%) | $323.00 M(-1.5%) | $1.33 B(-2.3%) |
| Sept 2021 | - | $328.00 M(-0.6%) | $1.37 B(-1.3%) |
| June 2021 | - | $330.00 M(-6.5%) | $1.38 B(-1.9%) |
| Mar 2021 | - | $353.00 M(-0.6%) | $1.41 B(-0.6%) |
| Dec 2020 | $1.42 B(+116.5%) | $355.00 M(+2.6%) | $1.42 B(+5.7%) |
| Sept 2020 | - | $346.00 M(-3.1%) | $1.34 B(+11.4%) |
| June 2020 | - | $357.00 M(-1.4%) | $1.21 B(+24.0%) |
| Mar 2020 | - | $362.00 M(+29.7%) | $973.00 M(+48.3%) |
| Dec 2019 | $656.00 M(+258.5%) | $279.00 M(+33.5%) | $656.00 M(+54.4%) |
| Sept 2019 | - | $209.00 M(+69.9%) | $425.00 M(+63.5%) |
| June 2019 | - | $123.00 M(+173.3%) | $260.00 M(+42.9%) |
| Mar 2019 | - | $45.00 M(-6.3%) | $182.00 M(-0.5%) |
| Dec 2018 | $183.00 M(-6.6%) | $48.00 M(+9.1%) | $183.00 M(-1.6%) |
| Sept 2018 | - | $44.00 M(-2.2%) | $186.00 M(-2.1%) |
| June 2018 | - | $45.00 M(-2.2%) | $190.00 M(-3.6%) |
| Mar 2018 | - | $46.00 M(-9.8%) | $197.00 M(+0.5%) |
| Dec 2017 | $196.00 M(+17.4%) | $51.00 M(+6.3%) | $196.00 M(+5.9%) |
| Sept 2017 | - | $48.00 M(-7.7%) | $185.00 M(+3.4%) |
| June 2017 | - | $52.00 M(+15.6%) | $179.00 M(+5.9%) |
| Mar 2017 | - | $45.00 M(+12.5%) | $169.00 M(+1.2%) |
| Dec 2016 | $167.00 M | $40.00 M(-4.8%) | $167.00 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $42.00 M(0.0%) | $170.00 M(+0.6%) |
| June 2016 | - | $42.00 M(-2.3%) | $169.00 M(-4.0%) |
| Mar 2016 | - | $43.00 M(0.0%) | $176.00 M(-4.3%) |
| Dec 2015 | $184.00 M(-9.4%) | $43.00 M(+4.9%) | $184.00 M(-5.2%) |
| Sept 2015 | - | $41.00 M(-16.3%) | $194.00 M(-4.4%) |
| June 2015 | - | $49.00 M(-3.9%) | $203.00 M(+1.5%) |
| Mar 2015 | - | $51.00 M(-3.8%) | $200.00 M(-1.5%) |
| Dec 2014 | $203.00 M(+2.0%) | $53.00 M(+6.0%) | $203.00 M(0.0%) |
| Sept 2014 | - | $50.00 M(+8.7%) | $203.00 M(+2.0%) |
| June 2014 | - | $46.00 M(-14.8%) | $199.00 M(-2.0%) |
| Mar 2014 | - | $54.00 M(+1.9%) | $203.00 M(+2.0%) |
| Dec 2013 | $199.00 M(+9.3%) | $53.00 M(+15.2%) | $199.00 M(+1.0%) |
| Sept 2013 | - | $46.00 M(-8.0%) | $197.00 M(-1.0%) |
| June 2013 | - | $50.00 M(0.0%) | $199.00 M(+4.7%) |
| Mar 2013 | - | $50.00 M(-2.0%) | $190.00 M(+4.4%) |
| Dec 2012 | $182.00 M(+25.5%) | $51.00 M(+6.3%) | $182.00 M(+5.2%) |
| Sept 2012 | - | $48.00 M(+17.1%) | $173.00 M(+4.8%) |
| June 2012 | - | $41.00 M(-2.4%) | $165.00 M(+5.8%) |
| Mar 2012 | - | $42.00 M(0.0%) | $156.00 M(+7.6%) |
| Dec 2011 | $145.00 M(0.0%) | $42.00 M(+5.0%) | $145.00 M(0.0%) |
| Sept 2011 | - | $40.00 M(+25.0%) | $145.00 M(+1.4%) |
| June 2011 | - | $32.00 M(+3.2%) | $143.00 M(0.0%) |
| Mar 2011 | - | $31.00 M(-26.2%) | $143.00 M(-1.4%) |
| Dec 2010 | $145.00 M(-21.2%) | $42.00 M(+10.5%) | $145.00 M(-0.7%) |
| Sept 2010 | - | $38.00 M(+18.8%) | $146.00 M(-5.8%) |
| June 2010 | - | $32.00 M(-3.0%) | $155.00 M(-6.1%) |
| Mar 2010 | - | $33.00 M(-23.3%) | $165.00 M(-10.3%) |
| Dec 2009 | $184.00 M(-40.6%) | $43.00 M(-8.5%) | $184.00 M(+30.5%) |
| Sept 2009 | - | $47.00 M(+11.9%) | $141.00 M(+50.0%) |
| June 2009 | - | $42.00 M(-19.2%) | $94.00 M(+80.8%) |
| Mar 2009 | - | $52.00 M(-28.8%) | $52.00 M(-28.8%) |
| Dec 2008 | $310.00 M | - | - |
| Mar 2008 | - | $73.00 M | $73.00 M |
FAQ
- What is Bristol-Myers Squibb annual interest expense?
- What is the all time high annual interest expense for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual interest expense year-on-year change?
- What is Bristol-Myers Squibb quarterly interest expense?
- What is the all time high quarterly interest expense for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly interest expense year-on-year change?
- What is Bristol-Myers Squibb TTM interest expense?
- What is the all time high TTM interest expense for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM interest expense year-on-year change?
What is Bristol-Myers Squibb annual interest expense?
The current annual interest expense of BMY is $1.17 B
What is the all time high annual interest expense for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual interest expense is $1.42 B
What is Bristol-Myers Squibb annual interest expense year-on-year change?
Over the past year, BMY annual interest expense has changed by -$66.00 M (-5.36%)
What is Bristol-Myers Squibb quarterly interest expense?
The current quarterly interest expense of BMY is $505.00 M
What is the all time high quarterly interest expense for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly interest expense is $521.00 M
What is Bristol-Myers Squibb quarterly interest expense year-on-year change?
Over the past year, BMY quarterly interest expense has changed by +$225.00 M (+80.36%)
What is Bristol-Myers Squibb TTM interest expense?
The current TTM interest expense of BMY is $1.77 B
What is the all time high TTM interest expense for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM interest expense is $1.77 B
What is Bristol-Myers Squibb TTM interest expense year-on-year change?
Over the past year, BMY TTM interest expense has changed by +$623.00 M (+54.46%)